Search Results - "Block, AnneMarie"

Prognostic Significance of the European LeukemiaNet Standardized System for Reporting Cytogenetic and Molecular Alterations in Adults With Acute Myeloid Leukemia by MROZEK, Krzysztof, MARCUCCI, Guido, PETTENATI, Mark J, HEEREMA, Nyla A, BLOCK, Annemarie W, PATIL, Shivanand R, BAER, Maria R, KOLITZ, Jonathan E, MOORE, Joseph O, CARROLL, Andrew J, STONE, Richard M, LARSON, Richard A, NICOLET, Deedra, BLOOMFIELD, Clara D, MAHARRY, Kati S, BECKER, Heiko, WHITMAN, Susan P, METZELER, Klaus H, SCHWIND, Sebastian, WU, Yue-Zhong, KOHLSCHMIDT, Jessica

“…To evaluate the prognostic significance of the international European LeukemiaNet (ELN) guidelines for reporting genetic alterations in acute myeloid leukemia…”
Get full text

Deciphering spatial genomic heterogeneity at a single cell resolution in multiple myeloma by Merz, Maximilian, Merz, Almuth Maria Anni, Wang, Jie, Wei, Lei, Hu, Qiang, Hutson, Nicholas, Rondeau, Cherie, Celotto, Kimberly, Belal, Ahmed, Alberico, Ronald, Block, AnneMarie W., Mohammadpour, Hemn, Wallace, Paul K., Tario, Joseph, Luce, Jesse, Glenn, Sean T., Singh, Prashant, Herr, Megan M., Hahn, Theresa, Samur, Mehmet, Munshi, Nikhil, Liu, Song, McCarthy, Philip L., Hillengass, Jens

“…Osteolytic lesions (OL) characterize symptomatic multiple myeloma. The mechanisms of how malignant plasma cells (PC) cause OL in one region while others show…”
Get full text

Ofatumumab plus HyperCVAD/HD‐MA induction leads to high rates of minimal residual disease negativity in patients with newly diagnosed mantle cell lymphoma: Results of a phase 2 study by Torka, Pallawi, Akhtar, Othman S., Reddy, Nishitha M., Baysal, Bora E., Kader, Angela, Groman, Adrienne, Nichols, Jenna, Mavis, Cory, Tario, Joseph D., Block, AnneMarie W., Sait, Sheila N. J., Ghione, Paola, Sundaram, Suchitra, Przespolewski, Eugene R., Mohr, Alice, Lund, Ian, Kostrewa, Jessica, McWhite, Kenneth, DeMarco, Joseph, Johnson, Michael, Darrall, Andrea, Thomas‐Talley, Rosh‐Neke, Wallace, Paul K., Neppalli, Vishala, Hutson, Alan, Hernandez‐Ilizaliturri, Francisco J.

“…Background Ofatumumab is a humanized type 1 anti‐CD20 monoclonal antibody. Preclinical studies show improved complement‐mediated cytotoxicity (CMC) compared to…”
Get full text

Low 25(OH) vitamin D3 levels are associated with adverse outcome in newly diagnosed, intensively treated adult acute myeloid leukemia by Lee, Hun Ju, Muindi, Josephia R., Tan, Wei, Hu, Qiang, Wang, Dan, Liu, Song, Wilding, Gregory E., Ford, Laurie A., Sait, Sheila N. J., Block, Annemarie W., Adjei, Araba A., Barcos, Maurice, Griffiths, Elizabeth A., Thompson, James E, Wang, Eunice S., Johnson, Candace S., Trump, Donald L., Wetzler, Meir

“…BACKGROUND Several studies have suggested that low 25(OH) vitamin D3 levels may be prognostic in some malignancies, but no studies have evaluated their impact…”
Get full text

Spatiotemporal assessment of immunogenomic heterogeneity in multiple myeloma by Merz, Maximilian, Hu, Qiang, Merz, Almuth Maria Anni, Wang, Jie, Hutson, Nicholas, Rondeau, Cherie, Celotto, Kimberly, Belal, Ahmed, Alberico, Ronald, Block, AnneMarie W., Mohammadpour, Hemn, Wallace, Paul K., Tario, Joseph, Luce, Jesse, Glenn, Sean T., Singh, Prashant, Samur, Mehmet, Munshi, Nikhil, Liu, Song, McCarthy, Philip L., Wei, Lei, Hillengass, Jens

“…•Clonal heterogeneity occurs especially in patients with extramedullary MM.•Residual disease, secondary cancers, site-specific high-risk clones, and drug…”
Get full text

Efficacy of lenalidomide in patients with chronic lymphocytic leukemia with high-risk cytogenetics by Sher, Taimur, Miller, Kena C., Lawrence, David, Whitworth, Amy, Hernandez-Ilizaliturri, Francisco, Czuczman, Myron S., Miller, Austin, Lawrence, William, Bilgrami, Syed Ali, Sood, Raman, Wood, Margaret T., Block, Annemarie W., Lee, Kelvin, Chanan-Khan, Asher Alban

“…Patients with chronic lymphocytic lymphoma (CLL) with high-risk cytogenetics [del(11q)(q22.3) or del(17p)(p13.1)] have limited therapeutic options and their…”
Get full text

Image cytometry‐based detection of aneuploidy by fluorescence in situ hybridization in suspension by Minderman, Hans, Humphrey, Kristen, Arcadi, Jane K., Wierzbicki, Andrzej, Maguire, Orla, Wang, Eunice S., Block, AnneMarie W., Sait, Sheila N. J., George, Thaddeus C., Wallace, Paul K.

“…Cytogenetic abnormalities are important diagnostic and prognostic criteria for hematologic malignancies. Karyotyping and fluorescence in situ hybridization…”
Get full text

Outcome of Induction and Postremission Therapy in Younger Adults With Acute Myeloid Leukemia With Normal Karyotype: A Cancer and Leukemia Group B Study by FARAG, Sherif S, RUPPERT, Amy S, STAMBERG, Judith, BAER, Maria R, BLOCK, Annemarie W, VARDIMAN, James W, KOLITZ, Jonathan E, SCHIFFER, Charles A, LARSON, Richard A, BLOOMFIELD, Clara D, MROZEK, Krzysztof, MAYER, Robert J, STONE, Richard M, CARROLL, Andrew J, POWELL, Bayard L, MOORE, Joseph O, PETTENATI, Mark J, KODURU, Prasad R. K

“…Evaluate the outcome of induction and postremission therapy in adults younger than 60 years with normal cytogenetics acute myeloid leukemia (AML). In 490…”
Get full text

The significance of quantifiable residual normal karyotype hematopoietic cells for toxicity and outcome by Vigil, Carlos, Block, Annemarie W., Wetzler, Meir

Get full text

Smoking adversely affects survival in acute myeloid leukemia patients by Varadarajan, Ramya, Licht, Andrea S., Hyland, Andrew J., Ford, Laurie A., Sait, Sheila N.J., Block, Annemarie W., Barcos, Maurice, Baer, Maria R., Wang, Eunice S., Wetzler, Meir

“…Smoking adversely affects hematopoietic stem cell transplantation outcome. We asked whether smoking affected outcome of newly diagnosed acute myeloid leukemia…”
Get full text

Is obesity a prognostic factor for acute myeloid leukemia outcome? by Lee, Hun Ju, Licht, Andrea S., Hyland, Andrew J., Ford, Laurie A., Sait, Sheila N. J., Block, AnneMarie W., Barcos, Maurice, Baer, Maria R., Wang, Eunice S., Wetzler, Meir

“…Obesity adversely affects outcome in pediatric acute lymphocytic leukemia and acute myeloid leukemia (AML). We asked if obesity, measured by body mass index…”
Get full text

Langerhans cell sarcoma arising from chronic lymphocytic lymphoma/small lymphocytic leukemia: lineage analysis and braf v600e mutation study by Chen, Weiwei, Jaffe, Ronald, Zhang, Linsheng, Hill, Charlie, Block, Anne, Sait, Sheila, Song, Boer, Liu, Yunguang, Cai, Donghong

“…Background: The phenomenon that histiocytic/dendritic cell sarcomas may be transformed from lymphoproliferative diseases is dubbed ′transdifferentiation′…”
Get full text

Phase 1 study of arsenic trioxide, high‐dose cytarabine, and idarubicin to down‐regulate constitutive signal transducer and activator of transcription 3 activity in patients aged <60 years with acute myeloid leukemia by Wetzler, Meir, Andrews, Chris, Ford, Laurie A., Tighe, Sheila, Barcos, Maurice, Sait, Sheila N. J., Block, AnneMarie W., Nowak, Norma J., Baer, Maria R., Wang, Eunice S., Baumann, Heinz

“…BACKGROUND: Constitutive activation of signal transducer and activator of transcription‐3 (STAT3) was detected in blasts from approximately 50% of patients…”
Get full text

Phase II trial of clofarabine and daunorubicin as induction therapy for acute myeloid leukemia patients greater than or equal to 60 years of age by Vigil, Carlos E, Tan, Wei, Deeb, George, Sait, Sheila N, Block, Annemarie W, Starostik, Petr, Griffiths, Elizabeth A, Thompson, James E, Greene, Jessica D, Ford, Laurie A, Wang, Eunice S, Wetzler, Meir

“…Abstract We designed a phase II study evaluating the upfront combination of clofarabine and daunorubicin in acute myeloid leukemia (AML) patients ≥ 60 years…”
Get full text

Central review of cytogenetics is necessary for cooperative group correlative and clinical studies of adult acute leukemia : The Cancer and Leukemia Group B experience by FMROZEK, Krzyszto, CARROLL, Andrew J, KODURU, Prasad R. K, BLOCK, Annemarie W, QUMSIYEH, Mazin B, EDWARDS, Colin G, STERLING, Lisa J, HOLLAND, Kelsi B, BLOOMFIELD, Clara D, MAHARRY, Kati, RAO, Kathleen W, PATIL, Shivanand R, PETTENATI, Mark J, WATSON, Michael S, ARTHUR, Diane C, TANTRAVAHI, Ramana, HEEREMA, Nyla A

“…The Cancer and Leukemia Group B has performed central review of karyotypes submitted by institutional cytogenetics laboratories from patients with acute…”
Get full text

Myeloid blastic transformation of myeloproliferative neoplasms—A review of 112 cases by Noor, Syed J, Tan, Wei, Wilding, Gregory E, Ford, Laurie A, Barcos, Maurice, Sait, Sheila N.J, Block, AnneMarie W, Thompson, James E, Wang, Eunice S, Wetzler, Meir

“…Abstract Blastic transformation of myeloproliferative neoplasms (MPN) is still poorly understood. We describe a cohort of 23 Roswell Park Cancer Institute…”
Get full text

Monoallelic and Biallelic Deletions of 13q14.3 in Chronic Lymphocytic Leukemia: FISH vs miRNA RT-qPCR Detection by SMONSKEY, Matthew T, BLOCK, Annemarie W, DEEB, George, CHANAN-KHAN, Asher A, BERNSTEIN, Zale P, MILLER, Kena C, WALLACE, Paul K, STAROSTIK, Petr

“…Deletion of 13q14.3 (del(13q)) is the most common cytogenetic abnormality in chronic lymphocytic leukemia (CLL) and implies a favorable prognosis. We explored…”
Get full text

Treating octogenarian and nonagenarian acute myeloid leukemia patients—Predictive prognostic models by Harb, Antoine J., Tan, Wei, Wilding, Gregory E., Ford, LaurieAnn, Sait, Sheila N. J., Block, AnneMarie W., Barcos, Maurice, Wallace, Paul K., Wang, Eunice S., Wetzler, Meir

“…BACKGROUND: Treating the octogenarian and nonagenarian patients who have acute myeloid leukemia (AML) with intensive chemotherapy is controversial. Several…”
Get full text

A GOG 210 aCGH study of gain at 1q23 in endometrioid endometrial cancer in the context of racial disparity and outcome by Morrison, Carl, Miecznikowski, Jeffrey, Darcy, Kathleen M., Dolce, Jean M., Kandel, Eugene, Erwin, Deborah O., Liu, Song, Shepherd, Lori, Cohn, David, McMeekin, D. Scott, Block, AnneMarie W., Nowak, Norma J., Maxwell, Larry

“…The goal of this study was to identify recurrent regions of genomic gain or loss in endometrial cancer of the endometrioid type in the context of racial…”
Get full text

Therapy-related myelodysplastic syndrome and acute myeloid leukemia following treatment of acute myeloid leukemia: Possible role of cytarabine by Arana-Yi, Cecilia, Block, AnneMarie W, Sait, Sheila N, Ford, Laurie A, Barcos, Maurice, Baer, Maria R

“…Abstract Therapy-related myelodysplastic syndrome and acute myeloid leukemia (t-MDS/t-AML) have been reported only rarely following treatment of AML. We report…”
Get full text